Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome
NCT00140257Phase 4Unknown
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Nov 2004
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by Bispebjerg and Frederiksberg Hospital. Status: unknown.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00140257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00140257.